441 related articles for article (PubMed ID: 21190448)
1. Thyroid pathology in PTEN-hamartoma tumor syndrome: characteristic findings of a distinct entity.
Laury AR; Bongiovanni M; Tille JC; Kozakewich H; Nosé V
Thyroid; 2011 Feb; 21(2):135-44. PubMed ID: 21190448
[TBL] [Abstract][Full Text] [Related]
2. Thyroid Pathology Findings in Cowden Syndrome: A Clue for the Diagnosis of the PTEN Hamartoma Tumor Syndrome.
Cameselle-Teijeiro J; Fachal C; Cabezas-Agrícola JM; Alfonsín-Barreiro N; Abdulkader I; Vega-Gliemmo A; Hermo JA
Am J Clin Pathol; 2015 Aug; 144(2):322-8. PubMed ID: 26185318
[TBL] [Abstract][Full Text] [Related]
3. Thyroid Follicular Cell-derived Carcinomas in a Background of Multiple Adenomatous Nodules Leading to a Diagnosis of
Liu A; Borges PM; Tay YS; Thompson LDR; Kong MX; Lai J
Anticancer Res; 2022 Mar; 42(3):1481-1485. PubMed ID: 35220242
[TBL] [Abstract][Full Text] [Related]
4. Abnormal distribution and hyperplasia of thyroid C-cells in PTEN-associated tumor syndromes.
Zambrano E; Holm I; Glickman J; Huang S; Perez-Atayde A; Kozakewich HP; Shamberger RC; Nosé V
Endocr Pathol; 2004; 15(1):55-64. PubMed ID: 15067177
[TBL] [Abstract][Full Text] [Related]
5. Thyroid nodules and cancer in children with PTEN hamartoma tumor syndrome.
Smith JR; Marqusee E; Webb S; Nose V; Fishman SJ; Shamberger RC; Frates MC; Huang SA
J Clin Endocrinol Metab; 2011 Jan; 96(1):34-7. PubMed ID: 20962022
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical staining of thyroidectomy specimens for PTEN can aid in the identification of patients with Cowden syndrome.
Barletta JA; Bellizzi AM; Hornick JL
Am J Surg Pathol; 2011 Oct; 35(10):1505-11. PubMed ID: 21921783
[TBL] [Abstract][Full Text] [Related]
7. Unexpected cancer-predisposition gene variants in Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome patients without underlying germline PTEN mutations.
Yehia L; Ni Y; Sesock K; Niazi F; Fletcher B; Chen HJL; LaFramboise T; Eng C
PLoS Genet; 2018 Apr; 14(4):e1007352. PubMed ID: 29684080
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathologic features of thyroid nodules with PTEN mutations on preoperative testing.
Quaytman JA; Nikiforov YE; Nikiforova MN; Morariu E
Endocr Relat Cancer; 2022 Sep; 29(9):513-520. PubMed ID: 35723418
[TBL] [Abstract][Full Text] [Related]
9. Cowden syndrome.
Gustafson S; Zbuk KM; Scacheri C; Eng C
Semin Oncol; 2007 Oct; 34(5):428-34. PubMed ID: 17920899
[TBL] [Abstract][Full Text] [Related]
10. Germline alterations in RASAL1 in Cowden syndrome patients presenting with follicular thyroid cancer and in individuals with apparently sporadic epithelial thyroid cancer.
Ngeow J; Ni Y; Tohme R; Song Chen F; Bebek G; Eng C
J Clin Endocrinol Metab; 2014 Jul; 99(7):E1316-21. PubMed ID: 24712574
[TBL] [Abstract][Full Text] [Related]
11. Mutation-positive and mutation-negative patients with Cowden and Bannayan-Riley-Ruvalcaba syndromes associated with distinct 10q haplotypes.
Pezzolesi MG; Li Y; Zhou XP; Pilarski R; Shen L; Eng C
Am J Hum Genet; 2006 Nov; 79(5):923-34. PubMed ID: 17033968
[TBL] [Abstract][Full Text] [Related]
12. PTEN hamartoma tumor syndromes in childhood: description of two cases and a proposal for follow-up protocol.
Piccione M; Fragapane T; Antona V; Giachino D; Cupido F; Corsello G
Am J Med Genet A; 2013 Nov; 161A(11):2902-8. PubMed ID: 24123798
[TBL] [Abstract][Full Text] [Related]
13. Germline PTEN promoter mutations and deletions in Cowden/Bannayan-Riley-Ruvalcaba syndrome result in aberrant PTEN protein and dysregulation of the phosphoinositol-3-kinase/Akt pathway.
Zhou XP; Waite KA; Pilarski R; Hampel H; Fernandez MJ; Bos C; Dasouki M; Feldman GL; Greenberg LA; Ivanovich J; Matloff E; Patterson A; Pierpont ME; Russo D; Nassif NT; Eng C
Am J Hum Genet; 2003 Aug; 73(2):404-11. PubMed ID: 12844284
[TBL] [Abstract][Full Text] [Related]
14. Analysis of prevalence and degree of macrocephaly in patients with germline PTEN mutations and of brain weight in Pten knock-in murine model.
Mester JL; Tilot AK; Rybicki LA; Frazier TW; Eng C
Eur J Hum Genet; 2011 Jul; 19(7):763-8. PubMed ID: 21343951
[TBL] [Abstract][Full Text] [Related]
15. Novel dermatological and skeletal features associated with PTEN variant in PTEN hamartoma tumor syndrome.
Comeau D; Allain V; Maillet-Lebel N; Ben Amor M
Eur J Med Genet; 2023 Aug; 66(8):104798. PubMed ID: 37307869
[TBL] [Abstract][Full Text] [Related]
16. PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome.
Marsh DJ; Kum JB; Lunetta KL; Bennett MJ; Gorlin RJ; Ahmed SF; Bodurtha J; Crowe C; Curtis MA; Dasouki M; Dunn T; Feit H; Geraghty MT; Graham JM; Hodgson SV; Hunter A; Korf BR; Manchester D; Miesfeldt S; Murday VA; Nathanson KL; Parisi M; Pober B; Romano C; Eng C
Hum Mol Genet; 1999 Aug; 8(8):1461-72. PubMed ID: 10400993
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer risk and clinical implications for germline PTEN mutation carriers.
Ngeow J; Sesock K; Eng C
Breast Cancer Res Treat; 2017 Aug; 165(1):1-8. PubMed ID: 26700035
[TBL] [Abstract][Full Text] [Related]
18. PTEN lipid phosphatase activity and proper subcellular localization are necessary and sufficient for down-regulating AKT phosphorylation in the nucleus in Cowden syndrome.
He X; Saji M; Radhakrishnan D; Romigh T; Ngeow J; Yu Q; Wang Y; Ringel MD; Eng C
J Clin Endocrinol Metab; 2012 Nov; 97(11):E2179-87. PubMed ID: 22962422
[TBL] [Abstract][Full Text] [Related]
19. Incidence and clinical characteristics of thyroid cancer in prospective series of individuals with Cowden and Cowden-like syndrome characterized by germline PTEN, SDH, or KLLN alterations.
Ngeow J; Mester J; Rybicki LA; Ni Y; Milas M; Eng C
J Clin Endocrinol Metab; 2011 Dec; 96(12):E2063-71. PubMed ID: 21956414
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
